Health Technology Assessment

Melbourne Health Economics, Centre for Health Policy

Health Technology Assessment (HTA) is a systematic process of evaluating the safety, clinical outcomes, and cost effectiveness of new and existing health technologies, including drugs, medical devices, procedures, and models of care.

About Us

Working together in a fun, collaborative team, we provide independent, high-quality research and health technology assessment services to support effective and efficient decision making.

An understanding of cost and value of treatments is crucial for guiding health policies, programs and discovery. In Australia, economic evidence of value has played a prominent role in policy decisions for government subsidy of pharmaceuticals and medical services. Our Unit works in collaboration with the Australian Government providing health technology assessment services to inform decisions about the funding of medicines and medical services.

The HTA team forms part of the Melbourne Health Technology and Value Assessment Collaboration (M-VAC). The team undertakes evaluations and provides formal commentaries to inform funding decisions of medicines considered by the Pharmaceutical Benefits Advisory Committee (PBAC) and medical services considered by the Medical Services Advisory Committee.

Our team works in collaboration with the Australian Government providing health technology assessment and support services to inform decisions about the funding of medicines and medical services. Since 2021, the team has undertaken evaluations and provided formal commentaries to inform funding decisions of:

  • Medicines considered by the Pharmaceutical Benefits Advisory Committee (PBAC)
  • Medical services considered by the Medical Services Advisory Committee (MSAC)
  • mRNA vaccines

M-VAC HTA team photo 2

Our People